Share
 
Title
Code
Session Type
Channel
Date Time
Co-Chairs:
16:15
RT01.01
Optimization of bNAbs for HIV prevention
Devin Sok, International AIDS Vaccine Initiative Neutralizing Antibody Center, United States
16:23
RT01.02
Engineered bispecific bNAbs
Magdalena Sobieszczyk, Columbia University Medical Centre, United States
16:31
RT01.03
Preclinical to clinical: 3BNC117 and 10-1074 bNAb combination for HIV prophylaxis
Marina Caskey, The Rockefeller University, United States
16:39
RT01.04
Passive bNAb infusion pipeline
Lynn Morris, National Institute for Communicable Diseases, South Africa
16:47
RT01.05
Antibodies against COVID-19
Marit van Gils, Academic Medical Center, Netherlands
16:55
RT01.06
Panel discussion